Cargando...
Clinical predictors of extrapyramidal symptoms associated with aripiprazole augmentation for the treatment of late-life depression in a randomized controlled trial
OBJECTIVE: Augmentation with aripiprazole is an effective pharmacotherapy for treatment resistant late-life depression (TRLLD). However, aripirprazole can cause extrapyramidal symptoms (EPS) such as akathisia and parkinsonism; these symptoms are distressing and can contribute to treatment discontinu...
Gardado en:
| Publicado en: | J Clin Psychiatry |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996023/ https://ncbi.nlm.nih.gov/pubmed/29924506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.17m11764 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|